BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21050062)

  • 21. Discharging patients from the nephrology clinic to primary care--will they get appropriate monitoring of renal function?
    Stevens KK; Woo YM; Rodger RS; Geddes CC
    QJM; 2009 Jun; 102(6):425-8. PubMed ID: 19376793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood pressure control and comorbidity in a nephrology clinic.
    Triolo L; Cattaruzza MS; Sicoli R; Ansali F; Malaguti M; Osborn J; Biagini M
    J Nephrol; 2004; 17(6):808-12. PubMed ID: 15593055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
    Delea TE; Hagiwara M; Stanford RH; Stempel DA
    Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation.
    Garg PP; Frick KD; Diener-West M; Powe NR
    N Engl J Med; 1999 Nov; 341(22):1653-60. PubMed ID: 10572154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Humanistic and economic impacts of hepatitis C infection in the United States.
    DiBonaventura MD; Wagner JS; Yuan Y; L'Italien G; Langley P; Ray Kim W
    J Med Econ; 2010; 13(4):709-18. PubMed ID: 21091098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Managing a dialysis clinic: the ever-changing landscape.
    Messana A
    Nephrol News Issues; 2013 Jun; 27(7):20-2. PubMed ID: 23855150
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of chronic kidney disease on individual and population medical expenditures in the Japanese population.
    Higashiyama A; Okamura T; Watanabe M; Murakami Y; Otsuki H; Adachi N; Kaneko C; Uehara E; Okayama A; Ueshima H
    Hypertens Res; 2009 Jun; 32(6):450-4. PubMed ID: 19373238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
    Jones C; Roderick P; Harris S; Rogerson M
    Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Healthcare resource utilization and expenditures of women diagnosed with hypoactive sexual desire disorder.
    Foley K; Foley D; Johnson BH
    J Med Econ; 2010; 13(4):583-90. PubMed ID: 20831458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The burden of illness associated with psoriasis: cost of treatment with systemic therapy and phototherapy in the US.
    Crown WH; Bresnahan BW; Orsini LS; Kennedy S; Leonardi C
    Curr Med Res Opin; 2004 Dec; 20(12):1929-36. PubMed ID: 15701211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs.
    Wei SY; Chang YY; Mau LW; Lin MY; Chiu HC; Tsai JC; Huang CJ; Chen HC; Hwang SJ
    Nephrology (Carlton); 2010 Feb; 15(1):108-15. PubMed ID: 20377778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An evaluation of a shared primary and secondary care nephrology service for managing patients with moderate to advanced CKD.
    Jones C; Roderick P; Harris S; Rogerson M
    Am J Kidney Dis; 2006 Jan; 47(1):103-14. PubMed ID: 16377391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficiency of implementing a program aimed at achieving early referral to the nephrologist of patients with chronic renal failure in primary care].
    Aguilar MD; Orte L; Lázaro P; Gómez-Campderá FJ; Fernández Giráldez E; Sanz Guajardo D; Pastor V;
    Nefrologia; 2006; 26 Suppl 3():114-20. PubMed ID: 17469437
    [No Abstract]   [Full Text] [Related]  

  • 34. Proposed conditions for coverage directed toward dialysis facilities.
    Smetanka S
    Health Care Law Mon; 2005 Apr; ():3-11. PubMed ID: 15895752
    [No Abstract]   [Full Text] [Related]  

  • 35. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
    Asche CV; Joish VN; Camacho F; Drake CL
    Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia.
    Berger A; Sadosky A; Dukes EM; Edelsberg J; Zlateva G; Oster G
    Am J Manag Care; 2010 May; 16(5 Suppl):S126-37. PubMed ID: 20586521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary hyperparathyroidism is associated with higher cost of care among chronic kidney disease patients with cardiovascular comorbidities.
    Khan S
    Nephron Clin Pract; 2007; 105(4):c159-64. PubMed ID: 17259740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States.
    Stack AG
    Am J Kidney Dis; 2003 Feb; 41(2):310-8. PubMed ID: 12552491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cost of hemodialysis in Iran.
    Arefzadeh A; Lessanpezeshki M; Seifi S
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):307-11. PubMed ID: 19237828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical status of the patient at the time of dialysis onset. INESIR study].
    Gómez-Campderá FJ; Orte L; Aguilar MD; Fernández Giráldez E; Lázaro P; Sanz Guajardo D;
    Nefrologia; 2006; 26 Suppl 3():12-8. PubMed ID: 17469422
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.